Striatal Cholinergic Interneurons Control Physical Nicotine Withdrawal via Muscarinic Receptor Signaling

Abstract Striatal cholinergic interneurons (ChIs) provide acetylcholine tone to the striatum and govern motor functions. Nicotine withdrawal elicits physical symptoms that dysregulate motor behavior. Here, the role of striatal ChIs in physical nicotine withdrawal is investigated. Mice under RNAi‐dep...

Full description

Saved in:
Bibliographic Details
Main Authors: Baeksun Kim, Han Ah Kim, Junsung Woo, Hyeon‐Jeong Lee, Tae Kyoo Kim, Hophil Min, C. Justin Lee, Heh‐In Im
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202402274
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846116836812259328
author Baeksun Kim
Han Ah Kim
Junsung Woo
Hyeon‐Jeong Lee
Tae Kyoo Kim
Hophil Min
C. Justin Lee
Heh‐In Im
author_facet Baeksun Kim
Han Ah Kim
Junsung Woo
Hyeon‐Jeong Lee
Tae Kyoo Kim
Hophil Min
C. Justin Lee
Heh‐In Im
author_sort Baeksun Kim
collection DOAJ
description Abstract Striatal cholinergic interneurons (ChIs) provide acetylcholine tone to the striatum and govern motor functions. Nicotine withdrawal elicits physical symptoms that dysregulate motor behavior. Here, the role of striatal ChIs in physical nicotine withdrawal is investigated. Mice under RNAi‐dependent genetic inhibition of striatal ChIs (ChIGI) by suppressing the sodium channel subunit NaV1.1, lessening action potential generation and activity‐dependent acetylcholine release is first generated. ChIGI markedly reduced the somatic signs of nicotine withdrawal without affecting other nicotine‐dependent or striatum‐associated behaviors. Multielectrode array (MEA) recording revealed that ChIGI reversed ex vivo nicotine‐induced alterations in the number of neural population spikes in the dorsal striatum. Notably, the drug repurposing strategy revealed that a clinically‐approved antimuscarinic drug, procyclidine, fully mimicked the therapeutic electrophysiological effects of ChIGI. Furthermore, both ChIGI and procyclidine prevented the nicotine withdrawal‐induced reduction in striatal dopamine release in vivo. Lastly, therapeutic intervention with procyclidine dose‐dependently diminished the physical signs of nicotine withdrawal. The data demonstrated that the striatal ChIs are a critical substrate of physical nicotine withdrawal and that muscarinic antagonism holds therapeutic potential against nicotine withdrawal.
format Article
id doaj-art-b40d567a972c4b5eb320a766c48d18b8
institution Kabale University
issn 2198-3844
language English
publishDate 2024-12-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj-art-b40d567a972c4b5eb320a766c48d18b82024-12-18T14:18:10ZengWileyAdvanced Science2198-38442024-12-011147n/an/a10.1002/advs.202402274Striatal Cholinergic Interneurons Control Physical Nicotine Withdrawal via Muscarinic Receptor SignalingBaeksun Kim0Han Ah Kim1Junsung Woo2Hyeon‐Jeong Lee3Tae Kyoo Kim4Hophil Min5C. Justin Lee6Heh‐In Im7Center for Brain Function Brain Science Institute Korea Institute of Science and Technology (KIST) Seoul 02792 Republic of KoreaCenter for Brain Function Brain Science Institute Korea Institute of Science and Technology (KIST) Seoul 02792 Republic of KoreaCenter for Glia‐Neuron Interaction Brain Science Institute KIST Seoul 02792 Republic of KoreaDoping Control Center KIST Seoul 02792 Republic of KoreaCenter for Brain Function Brain Science Institute Korea Institute of Science and Technology (KIST) Seoul 02792 Republic of KoreaDivision of Bio‐Medical Science & Technology KIST School Korea National University of Science and Technology (UST) Seoul 02792 Republic of KoreaCenter for Glia‐Neuron Interaction Brain Science Institute KIST Seoul 02792 Republic of KoreaCenter for Brain Function Brain Science Institute Korea Institute of Science and Technology (KIST) Seoul 02792 Republic of KoreaAbstract Striatal cholinergic interneurons (ChIs) provide acetylcholine tone to the striatum and govern motor functions. Nicotine withdrawal elicits physical symptoms that dysregulate motor behavior. Here, the role of striatal ChIs in physical nicotine withdrawal is investigated. Mice under RNAi‐dependent genetic inhibition of striatal ChIs (ChIGI) by suppressing the sodium channel subunit NaV1.1, lessening action potential generation and activity‐dependent acetylcholine release is first generated. ChIGI markedly reduced the somatic signs of nicotine withdrawal without affecting other nicotine‐dependent or striatum‐associated behaviors. Multielectrode array (MEA) recording revealed that ChIGI reversed ex vivo nicotine‐induced alterations in the number of neural population spikes in the dorsal striatum. Notably, the drug repurposing strategy revealed that a clinically‐approved antimuscarinic drug, procyclidine, fully mimicked the therapeutic electrophysiological effects of ChIGI. Furthermore, both ChIGI and procyclidine prevented the nicotine withdrawal‐induced reduction in striatal dopamine release in vivo. Lastly, therapeutic intervention with procyclidine dose‐dependently diminished the physical signs of nicotine withdrawal. The data demonstrated that the striatal ChIs are a critical substrate of physical nicotine withdrawal and that muscarinic antagonism holds therapeutic potential against nicotine withdrawal.https://doi.org/10.1002/advs.202402274cholinergic interneuronsdopaminedorsal striatummuscarinic receptorneural activitynicotine withdrawal
spellingShingle Baeksun Kim
Han Ah Kim
Junsung Woo
Hyeon‐Jeong Lee
Tae Kyoo Kim
Hophil Min
C. Justin Lee
Heh‐In Im
Striatal Cholinergic Interneurons Control Physical Nicotine Withdrawal via Muscarinic Receptor Signaling
Advanced Science
cholinergic interneurons
dopamine
dorsal striatum
muscarinic receptor
neural activity
nicotine withdrawal
title Striatal Cholinergic Interneurons Control Physical Nicotine Withdrawal via Muscarinic Receptor Signaling
title_full Striatal Cholinergic Interneurons Control Physical Nicotine Withdrawal via Muscarinic Receptor Signaling
title_fullStr Striatal Cholinergic Interneurons Control Physical Nicotine Withdrawal via Muscarinic Receptor Signaling
title_full_unstemmed Striatal Cholinergic Interneurons Control Physical Nicotine Withdrawal via Muscarinic Receptor Signaling
title_short Striatal Cholinergic Interneurons Control Physical Nicotine Withdrawal via Muscarinic Receptor Signaling
title_sort striatal cholinergic interneurons control physical nicotine withdrawal via muscarinic receptor signaling
topic cholinergic interneurons
dopamine
dorsal striatum
muscarinic receptor
neural activity
nicotine withdrawal
url https://doi.org/10.1002/advs.202402274
work_keys_str_mv AT baeksunkim striatalcholinergicinterneuronscontrolphysicalnicotinewithdrawalviamuscarinicreceptorsignaling
AT hanahkim striatalcholinergicinterneuronscontrolphysicalnicotinewithdrawalviamuscarinicreceptorsignaling
AT junsungwoo striatalcholinergicinterneuronscontrolphysicalnicotinewithdrawalviamuscarinicreceptorsignaling
AT hyeonjeonglee striatalcholinergicinterneuronscontrolphysicalnicotinewithdrawalviamuscarinicreceptorsignaling
AT taekyookim striatalcholinergicinterneuronscontrolphysicalnicotinewithdrawalviamuscarinicreceptorsignaling
AT hophilmin striatalcholinergicinterneuronscontrolphysicalnicotinewithdrawalviamuscarinicreceptorsignaling
AT cjustinlee striatalcholinergicinterneuronscontrolphysicalnicotinewithdrawalviamuscarinicreceptorsignaling
AT hehinim striatalcholinergicinterneuronscontrolphysicalnicotinewithdrawalviamuscarinicreceptorsignaling